StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Allarity Therapeutics's total assets was $32.12M at Jun 30, 2026. For fiscal 2025 it was $18.26M, down 19.4% from the year before. The highest annual figure on record is $49.63M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.26M-19.4%
FY2024Dec 31, 2024$22.65M+90.9%
FY2023Dec 31, 2023$11.86M-18.4%
FY2022Dec 31, 2022$14.54M-70.7%
FY2021Dec 31, 2021$49.63M+48.6%
FY2020Dec 31, 2020$33.40M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$32.12M+51.5%
Q1 FY2026Mar 31, 2026$34.92M+17.5%
Q4 FY2025Dec 31, 2025$18.26M-19.4%
Q3 FY2025Sep 30, 2025$20.80M+2.1%
Q2 FY2025Jun 30, 2025$21.21M-31.3%
Q1 FY2025Mar 31, 2025$29.73M+148.4%
Q4 FY2024Dec 31, 2024$22.65M+90.9%
Q3 FY2024Sep 30, 2024$20.38M+46.9%
Q2 FY2024Jun 30, 2024$30.88M+130.0%
Q1 FY2024Mar 31, 2024$11.97M-17.7%
Q4 FY2023Dec 31, 2023$11.86M-34.6%
Q3 FY2023Sep 30, 2023$13.88M-40.3%
Q2 FY2023Jun 30, 2023$13.43M-57.1%
Q4 FY2022Dec 31, 2022$14.54M-70.7%
Q3 FY2022Sep 30, 2022$18.13M-51.0%
Q2 FY2022Jun 30, 2022$23.23M-30.5%
Q1 FY2022Mar 31, 2022$31.29M–
Q4 FY2021Dec 31, 2021$49.63M–
Q3 FY2021Sep 30, 2021$36.99M–
Q4 FY2020Dec 31, 2020$33.40M–

More Allarity Therapeutics figures

See a number that looks wrong?